Raymond James Financial’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$686K Buy
380,873
+3,710
+1% +$7.44K ﹤0.01% 4333
2026
Q2
$845K Sell
377,163
-18,640
-5% -$35K ﹤0.01% 4123
2026
Q1
$354K Buy
395,803
+3,786
+1% +$3.58K ﹤0.01% 4577
2025
Q4
$396K Sell
392,017
-65,882
-14% -$81.8K ﹤0.01% 4417
2025
Q3
$614K Sell
457,899
-69,267
-13% -$73.5K ﹤0.01% 3994
2025
Q2
$416K Sell
527,166
-105,038
-17% -$124K ﹤0.01% 4113
2025
Q1
$645K Sell
632,204
-5,888
-0.9% -$11.1K ﹤0.01% 3771
2024
Q4
$1.58M Buy
+638,092
New +$1.23M ﹤0.01% 3139

Other funds holding IFRX

Raymond James Financial's IFRX Position: Q3 2026 in Review

Raymond James Financial increased its InflaRx (IFRX) stake by 0.98% in Q3 2026, buying an estimated $7.44K and bringing the position to 380,873 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #4333.

Raymond James Financial first reported a position in IFRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.58M in Q4 2024. 64 funds tracked by Wall St. Rank hold IFRX as of Q3 2026.

  • Raymond James Financial held 380,873 shares of InflaRx worth $686K as of Q3 2026.
  • Raymond James Financial bought 3,710 InflaRx shares in Q3 2026, an estimated $7.44K.
  • InflaRx made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4333 holding.
  • Raymond James Financial first reported a position in InflaRx in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's InflaRx position peaked at $1.58M in Q4 2024.
  • 64 funds tracked by Wall St. Rank held InflaRx as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.